AstraZeneca México, in collaboration with its A.Catalyst Network, announced the launch of the first Open Challenge as part of Mexico’s Health Innovation Hub. This challenge, unveiled during the “Health Day in Tech” organized by the Healthtech México Association, is designed to foster collaboration within the health ecosystem and advance in improving patients’ quality of life. The focus is on early prevention, diagnosis, and treatment using innovative technologies and disruptive processes.
The competition, including collaboration with Brixton Ventures Labs, will close its applications on December 22nd and focus on three therapeutic areas: Oncology, Cardiorenal-Metabolic Diseases, and Rare Diseases.
Winners will participate in an intensive four-month program to integrate their solutions into the primary care processes of the health system. In addition, they will receive financial support of USD $20,000, technological and innovation perks, and access to the A.Catalyst Network, mentorships, and the opportunity to become long-term allies of AstraZeneca.
During the event, Jesús López, Head of Digital & Innovation at AstraZeneca, highlighted the importance of initiatives like qTrack, an app for early lung cancer diagnosis that is already part of AstraZeneca’s innovation ecosystem. According to López, the goal is to develop more applications that challenge the limits of science and strengthen the health ecosystem.
Mexico’s Health Innovation Hub, in addition to the support of the Healthtech México Association, collaborates with partners such as Amplifica Capital, AWS, Global Health Intelligence, and the Insurtech México Association, among others. This initiative represents a collaborative effort to drive innovation in the health sector in Mexico, providing a platform for startups and innovators to present solutions that can effectively integrate into healthcare and significantly improve patient well-being.